NCT06903728尚未招募不适用
National forsøgsordning Med Glukosesensorer Til Type 2-diabetes: Glukosesensorer Til Gravide Med Type 2-diabetes
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 200
- 主要终点
- HbA1c at end of pregnancy (week 36 of pregnancy)
研究概览
简要总结
The goal of this clinical trial is to evaluate the use of glucose sensors in pregnant women with type 2 diabetes to improve insulin regulation, pregnancy and birth outcomes, and enhance quality of life and satisfaction with treatment.
The main questions it aims to answer are:
- Does the use of glucose sensors during pregnancy lead to a clinically significant reduction in HbA1c by 0.3% at 36 weeks gestation compared to the control group?
- Does the use of glucose sensors during pregnancy result in a clinically significant reduction in mean SD-score for birth weight deviation in newborns compared to the control group?
Researchers will compare the group of women using glucose sensors during pregnancy to a historical control group receiving routine care to see if the sensor improves pregnancy outcomes, glucose control, and birth weights.
Participants will:
- Use a glucose sensor from before 14 weeks of pregnancy until 4-6 weeks postpartum.
- Receive training on how to use the sensor and access ongoing support as needed.
- Have a follow-up appointment 4-6 weeks postpartum, including a consultation for advice on medical treatment and further management of diabetes after birth.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •pregnant women with type 2 diabetes
- •attending one of the four centers for pregnancy and diabetes in Denmark
- •18 years old or above
排除标准
- •gestationel age 14+0 or above
- •ekspected birth after end of trial
- •already using a continous glucose monitor (sensor)
结局指标
主要结局
HbA1c at end of pregnancy (week 36 of pregnancy)
时间窗: baseline < week 14 of pregnancy, follow up week 36 of pregnancy
child birth weight SD-score
时间窗: at time of birth
次要结局
- Birth related complications(at time of birth)
- Problem Areas in Diabetes (PAID)(Baseline, week 28, 4-6 weeks post partum)
- Mean glucose(from enrollment to 4-6 weeks post partum)
- TIR, TAR, TBR(from enrollment to 4-6 weeks post partum)
- Womens gestational wheight gain(from enrollment to birth)
- Hypoglykemia among newborn(at time of birth)
- Pregnancy related complications(from enrollment to birth)
- World Health Organisation - Five Well-Being Index (WHO-5)(Baseline, week 28, 4-6 weeks post partum)
- 12-Item Short-Form (SF12)(Baseline, week 28, 4-6 weeks post partum)
- Patient Assessment of Cronic Illness Care (PACIC)(Baseline, week 28, 4-6 weeks post partum)
- Glucose Monitoring Satisfaction Survey (GMSS)(Baseline, week 28, 4-6 weeks post partum)
- Pregnancy Physical Activity Questionnaire (PPAQ-DK(Baseline, week 28)
- Diet items from the National Danish Birth Cohort(Baseline, week 28)
研究者
相似试验
已完成
不适用
Maternal Glucose Measurement in Pregnancy Using a Continuous Ambulatory Subcutaneous MonitorPregnancyNCT00011622National Center for Research Resources (NCRR)
招募中
不适用
Continuous Glucose Monitor Use in PregnancyType 2 Diabetes Treated With InsulinPregnancy, High RiskNCT05317585University of Massachusetts, Worcester180
已完成
不适用
Flash Glucose Monitoring Targets in Gestational DiabetesGestational Diabetes Mellitus (GDM)NCT06774404University Medical Centre Ljubljana205
已完成
不适用
Diabetes Group Prenatal CarePregnancyGestational DiabetesType 2 DiabetesNCT02444325Washington University School of Medicine84
招募中
不适用
Gestational Diabetes After Gastric Bypass SurgeryDiabetes, GestationalGastric Bypass Status for Obesity Complicating Pregnancy, Childbirth, or the PuerperiumPregnancy in DiabeticBlood Glucose Self MonitoringNCT06291766Region Skane120